Viewing Study NCT00004895


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2026-04-07 @ 11:55 AM
Study NCT ID: NCT00004895
Status: COMPLETED
Last Update Posted: 2012-06-06
First Post: 2000-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery
Sponsor: Northwestern University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
None Constipation, Impaction, and Bowel Obstruction View
None Extrahepatic Bile Duct Cancer View
None Gastric Cancer View
None Gastrointestinal Stromal Tumor View
None Nausea and Vomiting View
None Ovarian Cancer View
None Pancreatic Cancer View
None Peritoneal Cavity Cancer View
None Small Intestine Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage I colon cancer View
None stage II colon cancer View
None stage III colon cancer View
None stage IV colon cancer View
None stage I gastric cancer View
None stage II gastric cancer View
None stage III gastric cancer View
None stage IV gastric cancer View
None recurrent gastric cancer View
None stage I pancreatic cancer View
None stage II pancreatic cancer View
None stage III pancreatic cancer View
None stage IV pancreatic cancer View
None recurrent pancreatic cancer View
None stage I rectal cancer View
None stage II rectal cancer View
None stage III rectal cancer View
None stage IV rectal cancer View
None recurrent colon cancer View
None recurrent rectal cancer View
None stage I ovarian epithelial cancer View
None stage II ovarian epithelial cancer View
None stage III ovarian epithelial cancer View
None stage IV ovarian epithelial cancer View
None recurrent ovarian epithelial cancer View
None small intestine adenocarcinoma View
None small intestine lymphoma View
None small intestine leiomyosarcoma View
None localized extrahepatic bile duct cancer View
None unresectable extrahepatic bile duct cancer View
None recurrent extrahepatic bile duct cancer View
None recurrent small intestine cancer View
None constipation, impaction, and bowel obstruction View
None peritoneal cavity cancer View
None nausea and vomiting View
None gastrointestinal stromal tumor View